City

Guangzhou (2)

Paris (2)

Kaiping (1)

Zhongshan (1)

Condition

Myocarditis (2)

Cardiac Complication (1)

Cardiomyopathies (1)

Cardiovascular Diseases (1)

Heart Diseases (1)

Hepatocellular Carcinoma (1)

Non-small Cell Lung Cancer (1)

Pericarditis (1)

Vasculitis (1)

Overall Status

Recruiting (3)

Completed (1)

Phase

n/a (1)

Sponsor

Groupe Hospitalier Pitie-Salpetriere (2)

Guangzhou University of Traditional Chinese Medicine (1)

Sun Yat-sen University (1)

Collaborator

Guangzhou No.12 People's Hospital (1)

Institute of Cardiometabolism and Nutrition, France (1)

Kaiping Central Hospital (1)

Vanderbilt University (1)

Vanderbilt University Medical Center (1)

ZhongShan People 's Hospital (1)

Intervention

ici (4)

antiviral prophylaxis (1)

bone-protecting and mass-dispersesing decoction (1)

chemotherapy (1)

placebo (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Other (4)

Study Type

Observational (2)

Interventional (1)

Observational [Patient Registry] (1)

ici

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors

Recruiting

Myocarditis
+5 more

Paris, France

AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C

Aug 19, 2022

HBV Reactivation Between High HBV-DNA and Low HBV-DNA Loads

Recruiting

Hepatocellular Carcinoma

ICI
Antiviral Prophylaxis

Guangzhou, Guangdong, China
+3 more

Jan 4, 2022

NSCLC Trial in Guangzhou (ICI, Chemotherapy, Placebo)

Recruiting

Non-small Cell Lung Cancer

ICI
+3 more

Guangzhou, Guangdong, China

Guangdong Provincial Hospital of Traditional Chinese Medicine

Aug 11, 2022

Myocarditis, Cardiac Complication Trial in Paris (ICI)

Completed

Myocarditis
Cardiac Complication

Paris, France

AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C

Sep 24, 2019